Janus Henderson Group
KYNB

Janus Henderson Group’s Kyntra Bio KYNB Stock Holding History

Janus Henderson Group’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,888
Closed -$128K – 2570
2023
Q2 		$128K Sell
1,888
-17,578
-90% -$7.27M ﹤0.01% 2545
2023
Q1 		$9.08M Buy
19,466
+4,432
+29% +$2.34M 0.01% 722
2022
Q4 		$6.02M Buy
15,034
+14,368
+2,157% +$5.5M ﹤0.01% 822
2022
Q3 		$217K Sell
666
-1
-0.1% -$322 ﹤0.01% 1861
2022
Q2 		$176K Buy
667
+1
+0.2% +$255 ﹤0.01% 2345
2022
Q1 		$200K Buy
666
+1
+0.2% +$349 ﹤0.01% 2441
2021
Q4 		$235K Buy
+665
New +$207K ﹤0.01% 2314
2021
Q3 		– Sell
-48,979
Closed -$32.6M – 2205
2021
Q2 		$32.6M Sell
48,979
-82,392
-63% -$47.5M 0.01% 669
2021
Q1 		$114M Sell
131,371
-4,616
-3% -$4.91M 0.05% 335
2020
Q4 		$126M Buy
135,987
+3,628
+3% +$3.81M 0.06% 314
2020
Q3 		$136M Buy
132,359
+4,153
+3% +$4.47M 0.07% 269
2020
Q2 		$130M Buy
128,206
+4,967
+4% +$4.61M 0.07% 265
2020
Q1 		$107M Buy
123,239
+17,651
+17% +$17.5M 0.07% 271
2019
Q4 		$113M Sell
105,588
-1,304
-1% -$1.33M 0.06% 335
2019
Q3 		$98.8M Buy
106,892
+6,869
+7% +$7.54M 0.05% 374
2019
Q2 		$113M Buy
100,023
+11,673
+13% +$12.8M 0.06% 344
2019
Q1 		$120M Buy
88,350
+18,921
+27% +$25.7M 0.07% 336
2018
Q4 		$80.3M Buy
69,429
+20,659
+42% +$23.2M 0.05% 409
2018
Q3 		$74.1M Sell
48,770
-6,269
-11% -$9.65M 0.04% 476
2018
Q2 		$86.1M Sell
55,039
-24,135
-30% -$31.5M 0.05% 413
2018
Q1 		$91.4M Sell
79,174
-603
-0.8% -$794K 0.05% 390
2017
Q4 		$94.5M Buy
79,777
+24,228
+44% +$30.4M 0.06% 387
2017
Q3 		$74.7M Sell
55,549
-963
-2% -$1.01M 0.05% 429
2017
Q2 		$45.6M Buy
+56,512
New +$39.4M 0.03% 536

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group's KYNB Position: Q3 2023 in Review

Janus Henderson Group sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 1,888 shares — an estimated $128K sold.

Janus Henderson Group first reported a position in KYNB in Q2 2017 and held it in 24 quarters. The position peaked at $136M in Q3 2020. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.

  • Janus Henderson Group reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
  • Janus Henderson Group sold 1,888 Kyntra Bio shares in Q3 2023, an estimated $128K.
  • Janus Henderson Group first reported a position in Kyntra Bio in Q2 2017 and held it in 24 quarters.
  • Janus Henderson Group's Kyntra Bio position peaked at $136M in Q3 2020.
  • 110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.

Based on Janus Henderson Group's 13F filing for Q3 2023, filed 14 Nov 2023.